Application no. and date | 17706945.7 (espacenet) (Federated) (European Patent Register), 20170213 | Patent/reg. no. and date | DK/EP 3416684, 20230621 | Publication date | 20181226 | Priority no. and date | US 201662296110 P, 20160217 | EP pub. no. and date |
EP 3416684 20181226 | Effective date | | Applicant/owner | Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road Tarrytown, NY 10591, US | Applicant ref. no. | V462690DK00 | Inventor | MURPHY, Andrew J., c/o Regeneron Pharmaceuticals Inc. 777 Old Saw Mill River Road
Tarrytown, New York 10591, US, GROMADA, Jesper, c/o Regeneron Pharmaceuticals Inc. 777 Old Saw Mill River Road
Tarrytown, New York 10591, US, GUSAROVA, Viktoria, c/o Regeneron Pharmaceuticals Inc. 777 Old Saw Mill River Road
Tarrytown, New York 10591, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 39/395 (2006.01) , A61P 3/06 (2006.01) , C07K 16/22 (2006.01) | Title | Fremgangsmåder til behandling eller forebyggelse af atherosklerose ved administration af en hæmmer af ANGPTL3 | Int. application no. | US2017017640 | Int. publication no. | WO2017142832 | Related patent (certificate) | | Status | Rettet DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|